Breaking News Instant updates and real-time market news.

LTRX

Lantronix

$2.57

0.025 (0.98%)

16:16
03/25/19
03/25
16:16
03/25/19
16:16

Lantronix appoints Paul Pickle CEO

Lantronix announced that Paul Pickle will be joining Lantronix as CEO of the company, effective April 22. Pickle will also join the company's board of directors. Most recently, Pickle served as COO of Microsemi Corporation from November 2013 until Microsemi was acquired by Microchip Technology in May 2018.

  • 01

    Apr

LTRX Lantronix
$2.57

0.025 (0.98%)

08/23/18
LSCM
08/23/18
NO CHANGE
Target $6
LSCM
Buy
Lantronix price target raised to $6 from $4 at Lake Street
Lake Street analyst Jaeson Schmidt raised his price target for Lantronix to $6 saying yesterday's "solid" Q4 results further illustrate the company's "steady execution and potential leverage in the model." The analyst believes the shares can see continued multiple expansion as investors gain confidence in the sustainability of the company's recent momentum. He sees "little to complain about" following the Q4 print and reiterates a Buy rating on Lantronix.
09/24/18
LSCM
09/24/18
NO CHANGE
Target $6
LSCM
Buy
Lantronix shares can see 'meaningful' multiple expansion, says Lake Street
Lake Street analyst Jaeson Schmidt believes Lantronix's equity offering last week gives the company "additional dry powder" to execute on its acquisition strategy. The analyst thinks the shares can see "meaningful" multiple expansion as investors gain confidence in the sustainability of the company's recent momentum. He reiterates a Buy rating on Lantronix with a $6 price target.
10/08/18
NEED
10/08/18
INITIATION
Target $5.5
NEED
Buy
Lantronix initiated with a Buy at Needham
Needham analyst Richard Valera initiated Lantronix with a Buy rating and a price target of $5.50, saying the company has reversed a trend of declining revenues since late 2015 under the leadership of its new CEO Jeff Benck. The analyst notes that the company is now growing and profitable, having ended FY18 on a strong note with a 9% revenue growth, as a result of new design wins in the Internet of Things realm along with its recent RFQ wins in IT management. Valera further states that if Lantronix can sustain its recent trajectory of improving sales and profitability, he sees shares rising even higher, adding that while some near term pressure related to China tariffs is possible, he sees those risks reflected in his valuation model.

TODAY'S FREE FLY STORIES

NSC

Norfolk Southern

$191.07

2.43 (1.29%)

06:34
12/12/19
12/12
06:34
12/12/19
06:34
Conference/Events
Norfolk Southern management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

EMR

Emerson

$75.75

1.21 (1.62%)

06:33
12/12/19
12/12
06:33
12/12/19
06:33
Initiation
Emerson initiated  »

Emerson initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VERU

Veru

$2.47

0.17 (7.39%)

06:33
12/12/19
12/12
06:33
12/12/19
06:33
Earnings
Veru reports Q4 EPS (5c), consensus (5c) »

Reports Q4 revenue $8.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TRKNY

Turk Telekom

$0.00

(0.00%)

06:31
12/12/19
12/12
06:31
12/12/19
06:31
Downgrade
Turk Telekom rating change  »

Turk Telekom downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKZOY

AkzoNobel

$0.00

(0.00%)

06:30
12/12/19
12/12
06:30
12/12/19
06:30
Upgrade
AkzoNobel rating change  »

AkzoNobel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGNX

Cognex

$52.45

1.51 (2.96%)

06:30
12/12/19
12/12
06:30
12/12/19
06:30
Initiation
Cognex initiated  »

Cognex initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLD

Americold Realty Trust

$35.03

-0.66 (-1.85%)

, INVH

Invitation Homes

$29.46

-0.42 (-1.41%)

06:29
12/12/19
12/12
06:29
12/12/19
06:29
Recommendations
Americold Realty Trust, Invitation Homes analyst commentary  »

Citi adds Americold…

COLD

Americold Realty Trust

$35.03

-0.66 (-1.85%)

INVH

Invitation Homes

$29.46

-0.42 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSG

Wanda Sports

$2.82

-0.01 (-0.35%)

06:28
12/12/19
12/12
06:28
12/12/19
06:28
Downgrade
Wanda Sports rating change  »

Wanda Sports downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

, SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

06:27
12/12/19
12/12
06:27
12/12/19
06:27
Downgrade
Glaukos, SeaSpine, Merit Medical, Medtronic, Teleflex rating change  »

SeaSpine, Glaukos…

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

MMSI

Merit Medical

$29.99

0.69 (2.35%)

MDT

Medtronic

$111.67

0.62 (0.56%)

TFX

Teleflex

$354.93

1.18 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

REG

Regency Centers

$62.65

-1.6 (-2.49%)

06:27
12/12/19
12/12
06:27
12/12/19
06:27
Downgrade
Regency Centers rating change  »

Regency Centers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRI

Weingarten Realty

$31.03

-0.41 (-1.30%)

06:26
12/12/19
12/12
06:26
12/12/19
06:26
Upgrade
Weingarten Realty rating change  »

Weingarten Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLCE

Children's Place

$54.36

-16.31 (-23.08%)

06:25
12/12/19
12/12
06:25
12/12/19
06:25
Downgrade
Children's Place rating change  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$74.56

-1.08 (-1.43%)

06:24
12/12/19
12/12
06:24
12/12/19
06:24
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADC

Agree Realty

$70.90

-1.34 (-1.85%)

06:23
12/12/19
12/12
06:23
12/12/19
06:23
Upgrade
Agree Realty rating change  »

Agree Realty upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$24.70

-0.17 (-0.68%)

06:22
12/12/19
12/12
06:22
12/12/19
06:22
Upgrade
VICI Properties rating change  »

VICI Properties upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDR

UDR, Inc.

$46.80

-0.95 (-1.99%)

06:21
12/12/19
12/12
06:21
12/12/19
06:21
Upgrade
UDR, Inc. rating change  »

UDR, Inc. upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DOC

Physicians Realty Trust

$18.64

-0.35 (-1.84%)

06:19
12/12/19
12/12
06:19
12/12/19
06:19
Upgrade
Physicians Realty Trust rating change  »

Physicians Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HR

Healthcare Realty Trust

$32.85

-0.59 (-1.76%)

06:18
12/12/19
12/12
06:18
12/12/19
06:18
Upgrade
Healthcare Realty Trust rating change  »

Healthcare Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,749.00

9.85 (0.57%)

06:18
12/12/19
12/12
06:18
12/12/19
06:18
Periodicals
Amazon sells children's smartwatches that are 'so easy to hack,' BI reports »

Amazon sells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$0.00

(0.00%)

06:16
12/12/19
12/12
06:16
12/12/19
06:16
Periodicals
SoftBank Vision Fund managing partner to leave company, Business Insider says »

Praveen Akkiraju, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$113.26

-0.32 (-0.28%)

06:15
12/12/19
12/12
06:15
12/12/19
06:15
Recommendations
Neurocrine analyst commentary  »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXAS

Exact Sciences

$85.16

-0.25 (-0.29%)

06:13
12/12/19
12/12
06:13
12/12/19
06:13
Hot Stocks
Exact Sciences announces new data supporting Oncotype DX Breast Recurrence Score »

Exact Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YETI

Yeti

$31.82

1.19 (3.89%)

06:12
12/12/19
12/12
06:12
12/12/19
06:12
Recommendations
Yeti analyst commentary  »

Piper highlights Yeti as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$35.23

0.13 (0.37%)

06:12
12/12/19
12/12
06:12
12/12/19
06:12
Hot Stocks
CEO of GM's Cruise unit hints at offering low-cost shared rides »

Dan Ammann, the former…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

WST

West Pharmaceutical

$146.54

1.07 (0.74%)

06:11
12/12/19
12/12
06:11
12/12/19
06:11
Downgrade
West Pharmaceutical rating change  »

West Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.